Applied Dna Sciences Inc financial data

Symbol
APDN on Nasdaq
Location
50 Health Sciences Drive, Stony Brook, NY
Fiscal year end
September 30
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 383 % +46.8%
Quick Ratio 18.2 % +33.5%
Debt-to-equity 32.8 % -75.1%
Return On Equity -136 % +1.62%
Return On Assets -102 % -72.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.29M shares -87.5%
Common Stock, Shares, Outstanding 902K shares -91.2%
Entity Public Float 5.7M USD -60.4%
Common Stock, Value, Issued 902 USD -91.2%
Weighted Average Number of Shares Outstanding, Basic 572K shares
Weighted Average Number of Shares Outstanding, Diluted 572K shares

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 2.31M USD +4.03%
Research and Development Expense 3.46M USD -6.39%
Operating Income (Loss) -13.4M USD +9.76%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -13M USD -76.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -13.2M USD -80.9%
Earnings Per Share, Basic 214 USD/shares -3005%
Earnings Per Share, Diluted 214 USD/shares -3005%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.73M USD -54.7%
Accounts Receivable, after Allowance for Credit Loss, Current 199K USD -61.3%
Inventory, Net 339K USD -27.9%
Assets, Current 5.63M USD -52.5%
Property, Plant and Equipment, Net 511K USD -3.68%
Operating Lease, Right-of-Use Asset 334K USD -61.5%
Intangible Assets, Net (Excluding Goodwill) 2.7M USD 0%
Assets 9.93M USD -40.5%
Accounts Payable, Current 615K USD -61.6%
Contract with Customer, Liability, Current 12.3K USD -76%
Liabilities, Current 2.04M USD -32.7%
Contract with Customer, Liability, Noncurrent 194K USD 0%
Deferred Income Tax Liabilities, Net 684K USD 0%
Operating Lease, Liability, Noncurrent 48.9K USD -92%
Liabilities 2.95M USD -33.9%
Retained Earnings (Accumulated Deficit) -374M USD -22%
Stockholders' Equity Attributable to Parent 7.26M USD -41.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.99M USD -42.9%
Liabilities and Equity 9.93M USD -40.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.33M USD +11.5%
Net Cash Provided by (Used in) Financing Activities 6.31M USD
Net Cash Provided by (Used in) Investing Activities -117K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 902K shares -91.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.86M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.48M USD -48.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 24.7M USD -20.2%
Deferred Tax Assets, Gross 24.9M USD -20.5%
Operating Lease, Liability 739K USD -40.3%
Payments to Acquire Property, Plant, and Equipment 117K USD
Lessee, Operating Lease, Liability, to be Paid 782K USD -42.9%
Property, Plant and Equipment, Gross 4.66M USD +9.69%
Operating Lease, Liability, Current 334K USD -37.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 195K USD -66.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 586K USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 42.6K USD -67.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 195K USD
Deferred Tax Assets, Operating Loss Carryforwards 18.5M USD -26.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 58.6K USD -80.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%